Skip to Main Content

Paper Details

Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts.
Cancer Discov
14
2022
AML, AML Blasts, AML blasts, AML cell, AML cells, IL1, IRF2BP2, Leukemic, Leukemic blasts, NF, TNF, acute myeloid leukemia, acute myeloid leukemia (AML) cells, blast, immune cells, leukemic, leukemic blasts
Author NameAffiliation
Gabriela AlexeDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Gabriela AlexeBoston University
Gabriela AlexeThe Broad Institute of MIT and Harvard
Gabriela AlexeDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Gabriela AlexeThe Broad Institute of MIT and Harvard
Gabriela AlexeBoston University
Lina BenajibaDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Lina BenajibaUniversite de Paris, INSERM U and CNRS 7212, Institut de Recherche Saint Louis
Yana PikmanDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Yana PikmanThe Broad Institute of MIT and Harvard
Nathanael S GrayChem-H and Stanford Cancer Institute, Stanford University
Nathanael S GrayChem-H and Stanford Cancer Institute, Stanford University
Stuart H OrkinDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Kimberly StegmaierDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Kimberly StegmaierThe Broad Institute of MIT and Harvard
Kimberly StegmaierDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Kimberly StegmaierThe Broad Institute of MIT and Harvard
  • 1 - 17

Datasets